Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David Scadden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sarah Gheuens - $1.55M of AGIO open-market activity in the last 12 months
- Brian Goff - $1.18M of AGIO open-market activity in the last 12 months
- Theodore James Washburn Jr. - $532K of AGIO open-market activity in the last 12 months
- Cecilia Jones - $389K of AGIO open-market activity in the last 12 months
- James William Burns - $265K of AGIO open-market activity in the last 12 months
- Tsveta Milanova - $196K of AGIO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David Scadden?
David Scadden is a corporate insider, tracked as Director of AGIOS PHARMACEUTICALS, INC. (AGIO). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Scadden submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has David Scadden been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($98K) across all tracked filings.
Where can I see all of David Scadden's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David Scadden and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
